vs
BillionToOne, Inc.（BLLN）与PDF SOLUTIONS INC（PDFS）财务数据对比。点击上方公司名可切换其他公司
BillionToOne, Inc.的季度营收约是PDF SOLUTIONS INC的1.3倍（$83.5M vs $62.4M），BillionToOne, Inc.净利率更高（6.8% vs -0.1%，领先6.9%），BillionToOne, Inc.同比增速更快（117.4% vs 24.6%），PDF SOLUTIONS INC自由现金流更多（$7.5M vs $6.5M）
BillionToOne, Inc.是一家生命科学与分子诊断企业，专注研发高精度基因检测解决方案，核心产品包括无创产前检测、肿瘤诊断试剂及罕见病筛查服务，服务全球多地的医疗机构、患者及科研合作方。
PDF Solutions Inc是一家总部位于美国加利福尼亚州圣克拉拉的跨国企业，主营软件业务与工程技术服务，目前在纳斯达克交易所挂牌上市，股票代码为PDFS。
BLLN vs PDFS — 直观对比
营收规模更大
BLLN
是对方的1.3倍
$62.4M
营收增速更快
BLLN
高出92.8%
24.6%
净利率更高
BLLN
高出6.9%
-0.1%
自由现金流更多
PDFS
多$1.1M
$6.5M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $83.5M | $62.4M |
| 净利润 | $5.7M | $-48.0K |
| 毛利率 | 69.9% | 72.9% |
| 营业利润率 | 11.5% | 5.5% |
| 净利率 | 6.8% | -0.1% |
| 营收同比 | 117.4% | 24.6% |
| 净利润同比 | 138.3% | -108.9% |
| 每股收益（稀释后） | $0.10 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BLLNPDFS
| Q4 25 | — | $62.4M | ||
| Q3 25 | $83.5M | $57.1M | ||
| Q2 25 | — | $51.7M | ||
| Q1 25 | — | $47.8M | ||
| Q4 24 | — | $50.1M | ||
| Q3 24 | $38.4M | $46.4M | ||
| Q2 24 | — | $41.7M | ||
| Q1 24 | — | $41.3M |
净利润BLLNPDFS
| Q4 25 | — | $-48.0K | ||
| Q3 25 | $5.7M | $1.3M | ||
| Q2 25 | — | $1.1M | ||
| Q1 25 | — | $-3.0M | ||
| Q4 24 | — | $539.0K | ||
| Q3 24 | $-14.9M | $2.2M | ||
| Q2 24 | — | $1.7M | ||
| Q1 24 | — | $-393.0K |
毛利率BLLNPDFS
| Q4 25 | — | 72.9% | ||
| Q3 25 | 69.9% | 72.3% | ||
| Q2 25 | — | 71.2% | ||
| Q1 25 | — | 72.9% | ||
| Q4 24 | — | 68.3% | ||
| Q3 24 | 52.6% | 73.1% | ||
| Q2 24 | — | 70.6% | ||
| Q1 24 | — | 67.3% |
营业利润率BLLNPDFS
| Q4 25 | — | 5.5% | ||
| Q3 25 | 11.5% | 8.5% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | -7.4% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | -32.9% | 4.6% | ||
| Q2 24 | — | 0.6% | ||
| Q1 24 | — | -4.7% |
净利率BLLNPDFS
| Q4 25 | — | -0.1% | ||
| Q3 25 | 6.8% | 2.3% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | -6.3% | ||
| Q4 24 | — | 1.1% | ||
| Q3 24 | -38.8% | 4.8% | ||
| Q2 24 | — | 4.1% | ||
| Q1 24 | — | -1.0% |
每股收益（稀释后）BLLNPDFS
| Q4 25 | — | $0.00 | ||
| Q3 25 | $0.10 | $0.03 | ||
| Q2 25 | — | $0.03 | ||
| Q1 25 | — | $-0.08 | ||
| Q4 24 | — | $0.01 | ||
| Q3 24 | $-1.47 | $0.06 | ||
| Q2 24 | — | $0.04 | ||
| Q1 24 | — | $-0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $195.2M | $42.2M |
| 总债务越低越好 | $55.0M | $67.0M |
| 股东权益账面价值 | $-239.5M | $271.0M |
| 总资产 | $327.5M | $418.7M |
| 负债/权益比越低杠杆越低 | — | 0.25× |
8季度趋势，按日历期对齐
现金及短期投资BLLNPDFS
| Q4 25 | — | $42.2M | ||
| Q3 25 | $195.2M | $35.9M | ||
| Q2 25 | — | $40.4M | ||
| Q1 25 | — | $54.1M | ||
| Q4 24 | — | $114.9M | ||
| Q3 24 | — | $120.2M | ||
| Q2 24 | — | $117.9M | ||
| Q1 24 | — | $122.9M |
总债务BLLNPDFS
| Q4 25 | — | $67.0M | ||
| Q3 25 | $55.0M | $67.6M | ||
| Q2 25 | — | $68.1M | ||
| Q1 25 | — | $68.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益BLLNPDFS
| Q4 25 | — | $271.0M | ||
| Q3 25 | $-239.5M | $264.4M | ||
| Q2 25 | — | $257.5M | ||
| Q1 25 | — | $249.0M | ||
| Q4 24 | — | $246.0M | ||
| Q3 24 | $-242.9M | $240.5M | ||
| Q2 24 | — | $232.2M | ||
| Q1 24 | — | $225.4M |
总资产BLLNPDFS
| Q4 25 | — | $418.7M | ||
| Q3 25 | $327.5M | $406.4M | ||
| Q2 25 | — | $391.1M | ||
| Q1 25 | — | $390.0M | ||
| Q4 24 | — | $315.3M | ||
| Q3 24 | — | $307.4M | ||
| Q2 24 | — | $298.0M | ||
| Q1 24 | — | $286.8M |
负债/权益比BLLNPDFS
| Q4 25 | — | 0.25× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.28× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.8M | $17.3M |
| 自由现金流经营现金流 - 资本支出 | $6.5M | $7.5M |
| 自由现金流率自由现金流/营收 | 7.7% | 12.1% |
| 资本支出强度资本支出/营收 | 8.8% | 15.7% |
| 现金转化率经营现金流/净利润 | 2.42× | — |
| 过去12个月自由现金流最近4个季度 | — | $-8.6M |
8季度趋势，按日历期对齐
经营现金流BLLNPDFS
| Q4 25 | — | $17.3M | ||
| Q3 25 | $13.8M | $3.3M | ||
| Q2 25 | — | $-5.2M | ||
| Q1 25 | — | $8.6M | ||
| Q4 24 | — | $1.6M | ||
| Q3 24 | — | $9.3M | ||
| Q2 24 | — | $684.0K | ||
| Q1 24 | — | $-1.9M |
自由现金流BLLNPDFS
| Q4 25 | — | $7.5M | ||
| Q3 25 | $6.5M | $-2.9M | ||
| Q2 25 | — | $-13.8M | ||
| Q1 25 | — | $535.0K | ||
| Q4 24 | — | $-4.0M | ||
| Q3 24 | — | $5.1M | ||
| Q2 24 | — | $-4.6M | ||
| Q1 24 | — | $-3.9M |
自由现金流率BLLNPDFS
| Q4 25 | — | 12.1% | ||
| Q3 25 | 7.7% | -5.1% | ||
| Q2 25 | — | -26.6% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | -8.0% | ||
| Q3 24 | — | 11.0% | ||
| Q2 24 | — | -11.1% | ||
| Q1 24 | — | -9.4% |
资本支出强度BLLNPDFS
| Q4 25 | — | 15.7% | ||
| Q3 25 | 8.8% | 10.8% | ||
| Q2 25 | — | 16.5% | ||
| Q1 25 | — | 17.0% | ||
| Q4 24 | — | 11.3% | ||
| Q3 24 | — | 9.0% | ||
| Q2 24 | — | 12.8% | ||
| Q1 24 | — | 4.9% |
现金转化率BLLNPDFS
| Q4 25 | — | — | ||
| Q3 25 | 2.42× | 2.54× | ||
| Q2 25 | — | -4.55× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.98× | ||
| Q3 24 | — | 4.20× | ||
| Q2 24 | — | 0.40× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
PDFS
| Volumebased | $38.0M | 61% |
| Other | $24.4M | 39% |
